![Toshimi Miyoshi](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Toshimi Miyoshi
Director/Board Member at FUNPEP COMPANY LIMITED
Net worth: 1 M $ as of 2024-05-30
Network origin in Toshimi Miyoshi first degree
Entity | Entity type | Industry | |
---|---|---|---|
Public Company | Biotechnology | 4 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Toshimi Miyoshi via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
RAQUALIA PHARMA INC. | Pharmaceuticals: Major | Director/Board Member | |
University of Washington
![]() University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Graduate Degree | |
Keio University | College/University | Graduate Degree | |
Lexwell Partners | Founder | ||
REGiMMUNE Corp.
![]() REGiMMUNE Corp. Pharmaceuticals: MajorHealth Technology REGiMMUNE Corp. develops solutions for treating immune disorders. Its focus is on the discovery, development, and commercialization of immune regulatory therapeutics to treat life-threatening and debilitating conditions, including allergies, autoimmune diseases and transplantation. The firm's platform technology, reVax, induces immune tolerance in an antigen-specific manner through pharmacological induction of regulatory T (Treg) cells. It also develops products for preventing inhibitor formation in enzyme replacement therapies (ERT) and for celiac disease with undisclosed partners. The company was founded by Yasuyuki Ishii on March 3, 2006 and is headquartered in Tokyo, Japan. | Pharmaceuticals: Major | Director/Board Member | |
Okinawa Protein Tomography Ltd.
![]() Okinawa Protein Tomography Ltd. Miscellaneous Commercial ServicesCommercial Services Okinawa Protein Tomography Ltd. provides polymeric molecular structure analysis services. Its technology allows imaging of macromolecules including proteins in multiple states at the single molecule-level by combining conventional electron tomography and a specifically designed 3D reconstruction program known as COMET. The firm analyzes data of molecular structures of protein samples. The company was founded by Akira Kamei on June 25, 2014 and is headquartered in Uruma, Japan. | Miscellaneous Commercial Services | Director/Board Member | |
ANGES, INC. | Pharmaceuticals: Generic | Director/Board Member | |
TOWA PHARMACEUTICAL CO., LTD. | Pharmaceuticals: Major | Director/Board Member | |
SOLASIA PHARMA K.K. | Pharmaceuticals: Major | Director/Board Member | |
KIDSWELL BIO CORPORATION | Biotechnology | Director/Board Member |
Statistics
International
Japan | 10 |
United States | 2 |
Sectoral
Health Technology | 7 |
Consumer Services | 3 |
Commercial Services | 2 |
Operational
Director/Board Member | 11 |
Independent Dir/Board Member | 5 |
Graduate Degree | 2 |
Founder | 2 |
Corporate Officer/Principal | 1 |
Most connected contacts
Insiders | |
---|---|
Akimitsu Hirai | 7 |
Norikazu Eiki | 5 |
Hideki Tomioka | 1 |
Taketoshi Hayashi | 1 |
- Stock Market
- Insiders
- Toshimi Miyoshi
- Company connections